• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

红细胞同种免疫受镰状细胞病患者输血时受体炎症状态的影响。

Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.

机构信息

Department of Transfusion Medicine, Children's National Medical Centre, Washington, DC, USA; Department of Haematology, Children's National Medical Centre, Washington, DC, USA.

出版信息

Br J Haematol. 2015 Jan;168(2):291-300. doi: 10.1111/bjh.13123. Epub 2014 Sep 26.

DOI:10.1111/bjh.13123
PMID:25256676
Abstract

Sickle cell disease (SCD) patients are at increased risk of red blood cell (RBC) alloimmunization. Recipient inflammatory state at time of transfusion has been shown to regulate alloimmunization in murine models, but evidence is lacking in SCD patients. We retrospectively studied a cohort of alloimmunized SCD patients to determine the influence of pro-inflammatory SCD-related complications at time of transfusion on alloimmunization. For each transfusion, the presence of pro-inflammatory state, degree of RBC antigen matching, unit age, storage solution and alloantibody detection date were ascertained. Transfusion-associated pro-inflammatory events were compared between transfusions resulting and not resulting in new alloantibodies. Univariate analysis and multivariate logistic regression were performed. Fifty-two patients received 3166 pre-storage leuco-reduced transfusions of which 128 resulted in alloantibodies. Transfusions during inflammatory events were associated with increased alloantibody risk on univariate and multivariate analysis; acute chest syndrome and vaso-occlusive crisis showed strongest associations with alloimmunization. Increased antigen matching demonstrated a protective effect on alloimmunization (univariate and multivariate analysis). Although an association was seen between citrate-phosphate-dextrose (adenine) stored units and alloimmunization on univariate analysis, no effect was found on multivariate analysis. Identifying recipient pro-inflammatory states at time of transfusion that promote alloimmunization can impact RBC unit selection decisions for SCD patients at risk for alloimmunization.

摘要

镰状细胞病 (SCD) 患者发生红细胞 (RBC) 同种免疫的风险增加。在鼠模型中已表明,输血时受者的炎症状态可调节同种免疫,但在 SCD 患者中缺乏相关证据。我们对一组同种免疫性 SCD 患者进行了回顾性研究,以确定输血时促炎的 SCD 相关并发症对同种免疫的影响。对于每一次输血,均确定了炎症状态、RBC 抗原匹配程度、单位年龄、储存液和同种抗体检测日期等因素。比较了导致和未导致新同种抗体产生的输血之间与输血相关的促炎事件。进行了单变量分析和多变量逻辑回归分析。52 例患者接受了 3166 次输血前白细胞减少的输血,其中 128 次导致了同种抗体。在单变量和多变量分析中,输血期间发生炎症事件与同种抗体风险增加相关;急性胸部综合征和血管阻塞性危象与同种免疫的相关性最强。增加抗原匹配对同种免疫具有保护作用(单变量和多变量分析)。虽然枸橼酸盐-磷酸盐-葡萄糖(腺嘌呤)储存单位与单变量分析中的同种免疫之间存在关联,但在多变量分析中未发现其影响。确定输血时促炎的受者状态可促进同种免疫,这可能会影响有同种免疫风险的 SCD 患者的 RBC 单位选择决策。

相似文献

1
Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.红细胞同种免疫受镰状细胞病患者输血时受体炎症状态的影响。
Br J Haematol. 2015 Jan;168(2):291-300. doi: 10.1111/bjh.13123. Epub 2014 Sep 26.
2
Red blood cell alloimmunization in sickle cell disease patients in Uganda.乌干达镰状细胞病患者的红细胞同种免疫。
Transfusion. 2010 Jan;50(1):20-5. doi: 10.1111/j.1537-2995.2009.02435.x. Epub 2009 Oct 10.
3
Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.红细胞抗原匹配对镰状细胞病患者同种免疫和输血并发症的影响:系统评价。
Transfus Med Rev. 2019 Jan;33(1):12-23. doi: 10.1016/j.tmrv.2018.07.003. Epub 2018 Jul 26.
4
Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.镰状细胞病患者红细胞同种免疫的早期发生。
Am J Hematol. 2016 Aug;91(8):763-9. doi: 10.1002/ajh.24397. Epub 2016 May 24.
5
Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series.红细胞同种免疫对镰状细胞病死亡率的影响:病例系列研究
Transfusion. 2016 Jan;56(1):107-14. doi: 10.1111/trf.13379. Epub 2015 Oct 28.
6
Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.对镰状细胞病患者输血后新的红细胞同种异体抗体进行筛查。
Transfusion. 2021 Aug;61(8):2255-2264. doi: 10.1111/trf.16444. Epub 2021 May 17.
7
HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease.HLA 同种免疫与镰状细胞病多次输血患者的 RBC 抗体有关。
Pediatr Blood Cancer. 2010 Apr;54(4):552-8. doi: 10.1002/pbc.22327.
8
Alloimmunization in transfused patients with constitutional anemias in Norway.挪威患有先天性贫血的输血患者中的同种免疫
Transfus Apher Sci. 2021 Oct;60(5):103257. doi: 10.1016/j.transci.2021.103257. Epub 2021 Aug 17.
9
Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.镰状细胞病患者的红细胞同种免疫和迟发性溶血性输血反应
Transfus Clin Biol. 2019 May;26(2):112-115. doi: 10.1016/j.tracli.2019.02.003. Epub 2019 Feb 22.
10
Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.镰状细胞病患儿的迟发性溶血性输血反应/高溶血综合征
Pediatrics. 2003 Jun;111(6 Pt 1):e661-5. doi: 10.1542/peds.111.6.e661.

引用本文的文献

1
Frequency of red blood cell allo-immunization in transfused patients with sickle cell disease in Africa: a systematic review with meta-analysis.非洲镰状细胞病输血患者红细胞同种免疫的发生率:一项荟萃分析的系统评价
Afr Health Sci. 2024 Sep;24(3):417-429. doi: 10.4314/ahs.v24i3.46.
2
Investigation of haematological, inflammatory parameters and the incidence of alloimmunization in multi-transfused sickle cell diseased patients.多次输血的镰状细胞病患者的血液学、炎症参数及同种免疫发生率的研究
Hematol Transfus Cell Ther. 2025 Jul 9;47(3):103937. doi: 10.1016/j.htct.2025.103937.
3
The Nrf2 Activator CDDO-Imidazole Suppresses Inflammation-Induced Red Blood Cell Alloimmunization.
Nrf2激活剂CDDO-咪唑可抑制炎症诱导的红细胞同种免疫。
Antioxidants (Basel). 2025 Jun 3;14(6):678. doi: 10.3390/antiox14060678.
4
Prophylactic versus on-demand transfusion in pregnant women with sickle cell disease: A systematic review and meta-analysis of randomised controlled trials.镰状细胞病孕妇预防性输血与按需输血的比较:随机对照试验的系统评价和荟萃分析。
EJHaem. 2025 Apr 24;6(2):e21086. doi: 10.1002/jha2.1086. eCollection 2025 Apr.
5
Clinics and genetics of hyperhemolysis syndrome in patients with sickle cell disease.镰状细胞病患者高溶血综合征的临床特征与遗传学研究
Transfusion. 2025 May;65(5):992-1000. doi: 10.1111/trf.18232. Epub 2025 Apr 2.
6
CRISPR-Cas9-driven antigen conversion of clinically relevant blood group systems.CRISPR-Cas9介导的临床相关血型系统的抗原转换
Hum Mol Genet. 2025 Jun 4;34(12):1001-1008. doi: 10.1093/hmg/ddaf040.
7
Harnessing the potential of red blood cells in immunotherapy.挖掘红细胞在免疫治疗中的潜力。
Hum Immunol. 2024 Nov;85(6):111084. doi: 10.1016/j.humimm.2024.111084. Epub 2024 Sep 9.
8
Increased memory phenotypes of CD4+ and CD8+ T cells in children with sickle cell anaemia in Tanzania.坦桑尼亚镰状细胞贫血患儿CD4+和CD8+ T细胞记忆表型增加。
Tanzan J Health Res. 2017 Apr;19(2). doi: 10.4314/thrb.v19i2.3. Epub 2017 Apr 8.
9
Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes.预防性红细胞输注治疗镰状细胞病妊娠:增加治疗的应用可能会改变结局。
Curr Opin Hematol. 2024 Nov 1;31(6):285-293. doi: 10.1097/MOH.0000000000000837. Epub 2024 Aug 22.
10
Frequency of red blood cell allo-immunization in patients undergoing blood transfusion at the Uganda Cancer Institute.乌干达癌症研究所接受输血患者的红细胞同种免疫频率。
Afr Health Sci. 2023 Dec;23(4):362-370. doi: 10.4314/ahs.v23i4.39.